Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Abbott Molecular, Inc. recalls In-vitro diagnostic kits: (1) Abbott Vysis LSI ATM (11q22.3) SpectrmOrange Probe

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.
Products
  • In-vitro diagnostic kits: (1) Abbott Vysis LSI ATM (11q22.3) SpectrmOrange Probe
Where it was sold

US Nationwide distribution in the states of AL, CA, IL, MA, MD, MN, NY, and PA.

States: Alabama, California, Illinois, Massachusetts, Maryland, Minnesota, New York, Pennsylvania

Barcodes
0088499900075900884999009301008849990098820088499900991200884999010451
Units affected
7 kits
About this recall
In-vitro diagnostic kits: (1) Abbott Vysis LSI ATM (11q22.3) SpectrmOrange Probe, REF 01N33-020; (2) Abbott Vysis PTEN/CEP 10 FISH Probe Kit, REF 04N62-020; (3) Abbott Vysis TelVysion 1p SpectrumGreen Probe, REF 05J03-001; (4) Abbott Vysis TelVysion 4P SpectrumGreen Probe, REF 05J03-004; (5) Abbott Vysis TelVysion 22q SpectrumOrange Probe, REF 05J04-022;